Approach to the Triple Negative Breast Cancer in New Drugs Area

Triple negative breast cancers (TNBCs) are associated with aggressive course, higher rates of visceral and central nervous system metastases and lower survival rate than hormone receptor positive. Once metastasis has occurred, a median survival was approximately one year. Currently, chemotherapy in...

Descripción completa

Detalles Bibliográficos
Autor principal: Mirzania, Mehrzad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences, Hematology-Oncology and Stem Cell Transplantation Research Center 2016
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4888149/
https://www.ncbi.nlm.nih.gov/pubmed/27252813

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4888149/
https://www.ncbi.nlm.nih.gov/pubmed/27252813

Ejemplares similares